Business Context and Reporting Period
Company: Hercules Technology Growth Capital, Inc. (HTGC)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2010
Business Overview: HTGC is a specialty finance company and Business Development Company (BDC) regulated under the Investment Company Act of 1940. It provides debt and equity growth capital to technology-related companies (software, life sciences, clean tech) at various stages of development. The company primarily invests in structured debt with warrants, senior debt, and equity securities. It operates two Small Business Investment Company (SBIC) subsidiaries, HT II and HT III.
Key Financial Metrics
| Metric | 2010 | 2009 |
|---|---|---|
| Total Assets | $591.2 million | $509.0 million |
| Total Investments (at value) | $472.0 million | $374.7 million |
| Total Net Assets | $412.5 million | $366.5 million |
| Net Asset Value (NAV) per Share | $9.50 | $10.29 |
| Net Investment Income | $29.4 million | $43.1 million |
| Net Realized Gain (Loss) | ($26.4 million) | ($30.8 million) |
| Net Increase in Net Assets from Operations | $5.0 million | $13.6 million |
| Cash and Cash Equivalents | $107.0 million | $124.8 million |
| Total Debt Outstanding | $170.0 million (SBA Debentures) | $130.6 million (SBA Debentures) |
| Unfunded Commitments | $117.2 million | $11.7 million |
Note: The company had no outstanding borrowings under its Wells Fargo or Union Bank credit facilities as of December 31, 2010.
Material Changes vs. Prior Period
- Portfolio Growth: The investment portfolio increased by approximately 26% to $472.0 million, driven by $320.4 million in funded debt commitments and $2.3 million in equity investments.
- Income Decline: Net investment income decreased by 32% to $29.4 million. This was primarily due to a lower average investment portfolio outstanding in 2010 compared to 2009 and a reduction in fee income ($4.8 million in 2010 vs. $12.1 million in 2009).
- Realized Losses: Net realized losses improved slightly to $26.4 million in 2010 from $30.8 million in 2009. Realized losses were driven by the disposition of investments in 10 portfolio companies.
- Investment Grading: The weighted average investment grading improved significantly from 2.71 in 2009 to 2.21 in 2010, reflecting improved operating performance and access to capital among portfolio companies.
- Capital Raise: In November 2010, the company completed a follow-on public offering of approximately 7.2 million shares, raising net proceeds of approximately $68.1 million.
Guidance, Outlook, and Risks
Management Commentary and Outlook
Management views the market for technology-related companies as improving, citing an improved IPO market in 2010. The company intends to continue investing in structured debt with warrants and equity of venture capital and private equity-backed technology companies. The Board increased the quarterly dividend by 10% to $0.22 per share in March 2011.
Risks and Contingencies
- Internal Control Material Weakness: Management identified a material weakness in internal control over financial reporting related to the valuation process for debt investments. The company corrected the process in Q4 2010, recognizing an additional $803,000 in unrealized depreciation, which was deemed immaterial to the 2010 financial statements.
- Liquidity and Capital Markets: The company faces risks related to the disruption of global capital markets, which could limit its ability to raise debt or equity capital. It currently has no outstanding borrowings under its Wells Facility and Union Bank Facility, though it has $170 million in SBA debentures.
- Valuation Uncertainty: Approximately 79.8% of total assets are investments valued at fair value by the Board of Directors. These valuations are inherently uncertain and may differ from values realized upon disposal.
- Concentration Risk: The portfolio is concentrated in technology-related sectors. The top 10 portfolio companies represented 57.5% of the total fair value of investments. Specific concentrations include Software (20.4%), Communications & Networking (13.8%), and Specialty Pharma (13.5%).
- Regulatory Constraints: As a BDC and RIC, the company is subject to asset coverage tests (200%) and distribution requirements (90% of taxable income) to maintain tax-advantaged status.
Key Facts for Investor Verification
- Valuation Methodology Correction: Verify the impact of the corrected ASC 820 valuation process on future quarters and the status of the remediation of the internal control material weakness.
- Dividend Sustainability: Confirm that net investment income ($29.4 million) remains sufficient to cover the quarterly dividend policy (approx. $0.80 per share annually) given the decline in income from 2009.
- Portfolio Quality: Monitor the 2.21 weighted average investment grade and the specific performance of the top 10 portfolio companies, which comprise over half the portfolio value.
- Capital Deployment: Track the funding of the $117.2 million in unfunded commitments and the ability to secure additional leverage under the Wells Facility or SBA program.
- Subsequent Events: Note the sale of InfoLogix, Inc. (a control investment) in January 2011, expected to generate a net gain of $8.0-$8.5 million in Q1 2011.